DERMTECH - Key Persons
Job Titles:
- Director
- Member of the Leadership Team
- President
Burkhard Jansen, M.D., is the President of DermTech, LLC, where he leads the company's efforts on strategy and stakeholder outreach to serve the dermatology community and its patients through non-invasive genomic testing for skin cancer. Dr. Jansen has contributed as founder, director, and senior executive of a number of dermatology and oncology focused life sciences companies, in the US, Canada, and Europe. He is a skin cancer expert with a background as a tenured professor of both dermatology and clinical pharmacology with FDA experience. His scientific work is published in leading peer reviewed journals including Nature, Nature Medicine, Lancet, and PNAS. Dr. Jansen received his medical doctorate and dermatology training from the Universities of Graz and Vienna in Austria, his postdoctoral science training at the University of Minnesota, and his executive business education at UCLA.
Jim is the Chairman of DermTech, LLC, where he leads the company's executive team in serving the dermatology community and its patients through non-invasive genomic testing for skin cancer. Jim is a board member of Stowers Resource Management Inc., the supporting organization to the Stowers Institute for Medical Research.
Jim served for 27 years with American Century Investment Management, Inc., where he held various roles, most recently serving as Chairman. He also serves on the Advisory Boards of The Children's Mercy Research Institute and Saint Luke's Marion Bloch Neuroscience Institute, and is a member of the University of Kansas Health Advancement Board. Additionally, Jim is a member of the Advisory Council for the Regnier Institute for Entrepreneurship and Innovation at the University of Missouri Kansas City. Jim holds a Bachelor of Science degree in Finance from Arizona State University.
Job Titles:
- Finance
- Head of Finance
- Member of the Leadership Team
- Operations Executive
Jeremy Teraoka, is the Head of Finance at DermTech, LLC. Mr. Teraoka is a seasoned finance and operations executive with extensive investment banking and biotech experience across North America, Asia and Europe. Trained in the UK with KPMG, Mr. Teraoka has held CFO, Finance Director, and Controller positions, working in both multinational corporations and fast-growing startups. As a co-founder and executive leader, he scaled the stockbroking firm Asia Equity, leading to its acquisition by Banque Paribas. Mr. Teraoka has a bachelor's degree in economics and philosophy from University College London (UCL).
Job Titles:
- Chief Medical Officer
- Director
- Member of the Leadership Team
Loren Clarke, M.D., is the Chief Medical Officer at DermTech, LLC, where he leads the company's clinical and scientific efforts in implementing advanced molecular diagnostics for skin cancer. Dr. Clarke has been at the forefront of the company's mission to revolutionize dermatological care through non-invasive genomic testing. A board-certified Pathologist and Dermatopathologist, Dr. Clarke brings extensive experience in clinical dermatopathology and molecular diagnostics. Prior to DermTech, he served as faculty at Penn State University's Hershey Medical Center and contributed to the development of novel molecular diagnostics for melanoma at Myriad Genetics. Dr. Clarke has contributed significantly to the medical and scientific literature, authoring or co-authoring over 60 peer-reviewed publications, as well as numerous book chapters and a textbook on Dermatopathology.